Lincoln Pharmaceuticals reports 13.27 per cent rise in standalone net profit at Rs 22.88 crores in…
Net revenues in Q2 FY22 at Rs 129.41 crores, up 4.78 per cent from Rs 123.51 crores in Q2 FY21
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lincoln Pharmaceuticals
NCLT approves amalgamation of Lincoln Parenteral and Lincoln Pharmaceuticals
"The amalgamation is expected to bring synergies in terms of operations efficiency, enhance competitive strength,…
Lincoln Pharmaceuticals reports standalone net profit of Rs 17.38 crores in Q1FY22
EBITDA for Q1FY22 was reported at Rs 26.31 crores, a rise of 17.37 per cent as compared to EBITDA of Rs 22.42 crores in Q1FY21
Lincoln Pharmaceuticals reports 28.33 per cent rise in standalone net profit in Q4 FY21
Company recommends dividend of 15 per cent – Rs 1.5 per share for FY21
Lincoln Pharmaceuticals receives EU GMP approval
The company looks to enter the EU markets very soon with its dermatology, gastro and pain management products and gradually expand…
Lincoln Pharma bets big on exports
Expects export business to cross Rs 225 crore in FY20 Lincoln Pharmaceuticals has reported export sales of Rs 174.7 crore for…
Lincoln Pharma posts net profit of Rs 10.92 crore for Q3 FY 2019-20
Net revenue for the quarter was at Rs 101.56 crore Lincoln Pharmaceuticals has posted its Q3FY19-20 results. The company…
Pharma Budget 2020
Pharma experts share their views and insights on the impact and implications of Budget 2020
Budget 2020: Pharma Wishlist
Leaders and experts from the pharma sector share their concerns and expectations from Budget 2020
Lincoln Pharmaceuticals reports consolidate net profit after tax at Rs 18.92 cr, up 26 per cent in…
Net revenues for Q2FY20 at Rs. 115.21crore, up 7.64% as compared to Rs.107.03 crore in Q2 FY19